JNJ Related Momentum Movers
-
Reuters Says EU Commission Cleared J&J's (JNJ) Buy of Synthes; Traders Selling
-
Dendreon (DNDN) Smacked on Positive Data from J&J's (JNJ) Zytiga
-
VIVUS (VVUS) Could Be Bought For Up to $40/Share
-
J&J (JNJ), CR Bard (BCR) Ordered to Study Injuries from Vaginal Implants -Bloomberg
-
Abbott (ABT) Shares Spike Higher as Humira Verdict Reversed (JNJ)
-
Crucell (CRXL), J&J (JNJ) Moving Higher as Progress Being Made on Intended Offer
-
BusinessWeek Highlights SuperGen (SUPG)
-
Immunicon (IMMC) Soars on FDA Clearance News
-
Morning Momentum Movers: UPI, SUPG, ERS
-
Stem Cells Stocks Up After WSJ Reports Big Firms Getting Involved in Embryonic Research
Back to JNJ Stock Lookup
